The Wall Street Journal gathers doctors' views on peptides and fertility, a question more people are raising as peptide use spreads.
Recap by typeshit. Full story at WSJ.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Medscape gives doctors guidance on getting GLP-1 coverage denials reversed for their patients. The full piece has the specifics.
Researchers describe a peptide and GPCR pair that lets a fungus sense when it has entered a host and switch on infection. Basic biology, not GLP-1 or wellness peptides.
Loading…